To address this knowledge gap, researchers set out to assess the real-life risk of intracranial meningioma associated with short-term (less than 1 year) and prolonged (1-7 or more years) use of ...

TOPLINE: The use of the calcitonin gene-related peptide (CGRP) antagonist rimegepant 75 mg for 52 weeks showed a favorable safety profile and sustained benefits for migraine prevention in a new ...

An extension trial revealed that long-term anifrolumab treatment improved health status and health-related quality of life in patients with moderate to severe systemic lupus erythematosus.

NSAID use was associated with lower dementia risk for long-term users (hazard ratio, 0.88) and with elevated risk for short-term and intermediate-term use (hazard ratios, 1.04 and 1.04, respectively).